BlueCrest Capital Management’s Imperva, Inc. IMPV Stock Holding History

BlueCrest Capital Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,400	Closed	-$1.02M	–	1482
2018 Q4	$1.02M	Buy	18,400 +11,287	+159%	+$613K	0.05%	210
2018 Q3	$330K	Buy	+7,113	New	+$344K	0.01%	988
2018 Q2	–	Sell	-8,697	Closed	-$377K	–	2044
2018 Q1	$377K	Buy	+8,697	New	+$391K	0.01%	920
2016 Q4	–	Sell	-9,600	Closed	-$516K	–	974
2016 Q3	$516K	Buy	+9,600	New	+$446K	0.02%	512
2016 Q2	–	Sell	-6,239	Closed	-$315K	–	1138
2016 Q1	$315K	Buy	+6,239	New	+$300K	0.02%	577
2015 Q2	–	Sell	-7,001	Closed	-$299K	–	988
2015 Q1	$299K	Buy	+7,001	New	+$311K	0.02%	525

BlueCrest Capital Management's IMPV Position: Q1 2019 in Review

BlueCrest Capital Management sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 18,400 shares — an estimated $1.02M sold.

BlueCrest Capital Management first reported a position in IMPV in Q1 2015 and held it in 6 quarters. The position peaked at $1.02M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

BlueCrest Capital Management reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
BlueCrest Capital Management sold 18,400 Imperva, Inc. shares in Q1 2019, an estimated $1.02M.
BlueCrest Capital Management first reported a position in Imperva, Inc. in Q1 2015 and held it in 6 quarters.
BlueCrest Capital Management's Imperva, Inc. position peaked at $1.02M in Q4 2018.
0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.